We use cookies to make sure that our website works properly, to keep you logged-in, and to enable online payments. We do NOT use any cookies for advertisement. By clicking "Accept" you consent to the use of all our cookies. See our cookie policy here.
Alessia Fornoni obtained both her Ph.D. in Medical Pharmacology and her M.D. from the University of Pavia, Italy. In parallel she did her Intern at the Nephrology and Dialysis Unit, University Hospital Policlinico San Matteo, Pavia. In 2001, she started working as a House-staff physician in Internal Medicine, Jackson Memorial Hospital, Miami. She continued her work as an assistant professor at the University of Miami School of Medicine, before becoming associate professor and chair at the Peggy and Harold Katz Family Drug Discovery Center. Since 2016, she is also chief of the division of Nephrology and Hypertension, University of Miami.
Her research interests focus on metabolic signaling pathways and their impact on podocyte function in kidney and beta cell function in pancreas. Prof. Fornoni and her lab members were the first ones to identify important roles of spingholipids and cholesterol in podocytes. Next to basic research approaches, Prof. Fornoni impresses with her experience in running clinical studies that involve experimental therapeutics.
Speakers
Prof. Annette Schürmann (German Institute of Human Nutrition Potsdam - Rehbrücke)
Prof. Susanne Mandrup (University of Southern Denmark, Odense)
Dr. Anja Zeigerer (Institute for Diabetes and Cancer, Helmholtz Center Munich)
Prof. Alessia Fornoni (University of Miami School of Medicine, USA)
PD Dr. Susanna Bianzano (Boehringer - Ingelheim, Ingelheim)
Dr. Seraphine Wegner (Max Planck Institute for Polymer Research, Mainz)
Dr. Lise Roth (EMBO Molecular Medicine, Heidelberg)
Login
